Bharat Krushna Khuntia, Aman Agarwal, & Gautam Sharma. (2022). Letter to Editor on 'A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India'. Elsevier.
Chicago Style (17th ed.) CitationBharat Krushna Khuntia, Aman Agarwal, and Gautam Sharma. Letter to Editor on 'A Randomized, Controlled, Blinded, Parallel-group, Clinical Trial to Study the Role of Ayurcov (AyurCoro3), a One-day Regimen as an Adjuvant Therapy for COVID-19 Disease Management, at Dedicated Covid Hospital (DCH) in India'. Elsevier, 2022.
MLA (9th ed.) CitationBharat Krushna Khuntia, et al. Letter to Editor on 'A Randomized, Controlled, Blinded, Parallel-group, Clinical Trial to Study the Role of Ayurcov (AyurCoro3), a One-day Regimen as an Adjuvant Therapy for COVID-19 Disease Management, at Dedicated Covid Hospital (DCH) in India'. Elsevier, 2022.